Notably, miR-22 is under-expressed in CHD patients, and miR-22 could suppress the expression of IL-1β, IL-6 and IL-18 and apoptosis of coronary arterial endothelial cells to protect against CHD [13]. Here, IL1B is linked to coronary artery disorder.